News AstraZeneca PLC Deutsche Boerse AG

Equities

ZEG

GB0009895292

Real-time Estimate Tradegate Other stock markets 10:21:33 2024-07-16 EDT			5-day change	1st Jan Change
143.8 ^EUR	-0.16%		+0.81%	+17.36%

07-15	Global markets live: Airbus, Burberry, AT&T, Boeing, Vinfast...
07-15	AstraZeneca: acquisition of Amolyt Pharma finalized	CF

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Global markets live: Airbus, Burberry, AT&T, Boeing, Vinfast...	07-15
AstraZeneca : Acquisition of Amolyt Pharma completed Form 6 K	07-15	PU
AstraZeneca: acquisition of Amolyt Pharma finalized	07-15	CF
AstraZeneca Closes $1.05 Billion Amolyt Pharma Acquisition	07-15	MT
AstraZeneca : Acquisition of Amolyt Pharma completed	07-15	PU
AstraZeneca PLC completed the acquisition of Amolyt Pharma SAS for $1.05 billion.	07-14	CI
Instil Bio Shares Surge Following Rental Agreement with AstraZeneca	07-12	DJ
Sector Update: Health Care Stocks Mixed Premarket Friday	07-12	MT
Instil Bio Signs Lease With AstraZeneca Pharmaceuticals at California Facility; Shares Rise After Hours	07-11	MT
Selkirk Pharma, Inc. - Colleen Dixon Appointed CEO	07-10	AQ
ASTRAZENECA : Deutsche Bank reiterates its Neutral rating	07-10	ZD
Barclays raises Kerry, cuts Hunting, Wood Group	07-10	AN
ASTRAZENECA : JP Morgan reaffirms its Buy rating	07-10	ZD
Non-Hodgkin Lymphoma Pipeline 2024 \| Novartis, AstraZeneca, Genentech, BioInvent, Genmab, SystImmune, Nordic Nanovector, Pacylex Pharmaceuticals, Artiva Biotherapeutics, Inc., Chipscreen Biosciences	07-09	AQ
Metastatic Renal Cell Carcinoma Pipeline 2024 \| AstraZeneca, Genentech, Sumitomo Dainippon Pharma, Allogene Therapeutics, Nektar Therapeutics	07-09	AQ
Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series a Cumulative Redeemable Perpetual Preferred Stock	07-08	AQ
Astrazeneca - Tagrisso with the addition of chemotherapy approved in the EU as new 1st-line treatment for patients with EGFR-mutated advanced lung cancer	07-08	AQ
AstraZeneca's Tagrisso Approved by EU as First-Line Treatment for Non-Small Cell Lung Cancer	07-05	MT
AstraZeneca: cancer treatment approved by the EU	07-05	CF
AstraZeneca drug Tagrisso gets EU approval for cancer form	07-05	AN

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 12:02 pm